Gencurix

A new paradigm in molecular diagnostics through advanced liquid biopsy

Gencurix is headquartered in Seoul, South Korea, lists 51–200 employees, and has $52.1M in recorded funding across 3 rounds.

Headquarters
Seoul
Employees
51–200
Business Model
B2B
Total Funding
$52.1M
Last Round
$24.0M Series AMar 2026
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 3 investors for this company. The full record is or through the API.

About

Gencurix (젠큐릭스) is a South Korean molecular diagnostics biotech company specializing in liquid biopsy and digital PCR-based cancer diagnostics. The company was the first Asian company to develop a prognostic diagnostic test for breast cancer and offers a portfolio of CE-IVD certified products including the Droplex cancer gene mutation detection kit, the GenesWell BCT breast cancer test, and the eDX early cancer detection system. In 2025, Gencurix signed a global supply and co-marketing agreement with Bio-Rad Laboratories — the world's largest digital PCR diagnostics company — to distribute its Droplex kits across Europe, marking a major commercial milestone for the company.

Summary

Gencurix is a Biotech company based in Seoul, South Korea. It lists 51–200 employees. It has raised $52.1M in total across 3 rounds, most recently a $24.0M Series A round in Mar 2026. Investors include HG Initiative-Mega Investment, Korea Investment Partners and Union Ventures.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AMar 2026
$24.0M

Sign up to see all 3 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Gencurix on Indexed.vc
<a href="https://indexed.vc/companies/gencurix"><img src="https://indexed.vc/api/badge/company/gencurix" alt="Gencurix on Indexed.vc" width="260" height="76" /></a>